Department of Orofacial Pain and TMJ Disorders, Eastman Institute for Oral Health, University of Rochester, 625 Elmwood Avenue, Rochester, NY, 14620, USA.
Department of Orthodontics and Dentofacial Orthopedics, Eastman Institute for Oral Health, University of Rochester, 625 Elmwood Avenue, Rochester, NY, USA.
Eur Arch Paediatr Dent. 2023 Jun;24(3):279-292. doi: 10.1007/s40368-023-00795-1. Epub 2023 Apr 6.
To evaluate self-perceived pain levels in the Hyrax compared to other types of maxillary expansion (ME) appliances in growing patients.
An unrestricted search of indexed databases and manual searching were performed up to October 2022. Randomized controlled trials (RCTs) comparing the Hyrax appliance with other ME appliances were included. Data screening, extraction, and Risk of Bias (RoB) assessment with the Cochrane tool were performed by two authors.
Six RCTs were included. The number of participants in the included RCTs ranged between 34 to 114 and included both male and female growing patients. Various tools were used to measure self-perceived pain including the Graphic Rating Scale for Pain, the Wong-Baker Faces Pain Scale, the Numerical Rating Scale, the visual analogue scale, and a questionnaire. One RCT reported that pain intensity in patients treated with the Hyrax was higher than in the Haas appliance, with a statistically significant difference limited to the first day. Two RCTs reported that pain intensity in patients treated with the Leaf expander was lower than in the Hyrax during the first 7 days of treatment. Two RCTs reported no significant differences in pain intensity between the Hyrax and other ME appliances. One RCT reported that pain intensity in patients using the computer-guided skeletal ME appliance was higher than in the Hyrax appliance at the first day after expansion. Four RCTs had a high RoB, and two RCTs had a moderate RoB.
Within the limitations of the present systematic review and based on the currently available evidence, it is challenging and inconclusive to identify the best maxillary expansion appliances, regarding pain levels for growing patients.
评估 Hyrax 与其他类型上颌扩展(ME)器具在生长患者中的自我感知疼痛程度。
对索引数据库进行无限制搜索,并手动搜索至 2022 年 10 月。纳入比较 Hyrax 器具与其他 ME 器具的随机对照试验(RCT)。由两名作者进行数据筛选、提取和 Cochrane 工具的偏倚风险(RoB)评估。
纳入了 6 项 RCT。纳入 RCT 的参与者人数从 34 到 114 人不等,包括男性和女性生长患者。各种工具被用于测量自我感知的疼痛,包括疼痛分级量表、Wong-Baker 面部疼痛量表、数字评分量表、视觉模拟量表和问卷。一项 RCT 报道称,接受 Hyrax 治疗的患者疼痛强度高于 Haas 器具,且仅在第一天具有统计学显著差异。两项 RCT 报道称,在治疗的前 7 天,接受 Leaf 扩张器治疗的患者疼痛强度低于 Hyrax。两项 RCT 报道称,Hyrax 与其他 ME 器具之间的疼痛强度无显著差异。一项 RCT 报道称,在扩张后第一天,使用计算机引导骨骼 ME 器具的患者疼痛强度高于 Hyrax 器具。四项 RCT 的 RoB 较高,两项 RCT 的 RoB 为中度。
根据本系统评价的限制和现有证据,很难确定哪种上颌扩展器具最适合生长患者,因为它们的疼痛水平存在争议,尚无定论。